PDB43 COST COMPARISON OF GLICAZIDE MODIFIED-RELEASE AND GENERIC GLICLAZIDE IN PREVENTING END STAGE RENAL DISEASE IN TYPE 2 DIABETES MELLITUS IN THE PUBLIC SECTOR OF MALAYSIA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.925
https://www.valueinhealthjournal.com/article/S1098-3015(19)33303-0/fulltext
Title :
PDB43 COST COMPARISON OF GLICAZIDE MODIFIED-RELEASE AND GENERIC GLICLAZIDE IN PREVENTING END STAGE RENAL DISEASE IN TYPE 2 DIABETES MELLITUS IN THE PUBLIC SECTOR OF MALAYSIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33303-0&doi=10.1016/j.jval.2019.09.925
First page :
Section Title :
Open access? :
No
Section Order :
10819